CCM
MED icon

Copeland Capital Management’s Medifast MED Stock Holding History

Copeland Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-234
Closed -$21.6K – 310
2023
Q2 		$21.6K Sell
234
-57
-20% -$5.08K ﹤0.01% 203
2023
Q1 		$30K Buy
291
+23
+9% +$2.55K ﹤0.01% 190
2022
Q4 		$31K Buy
268
+5
+2% +$582 ﹤0.01% 182
2022
Q3 		$28K Buy
+263
New +$37.7K ﹤0.01% 182

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Copeland Capital Management's MED Position: Q3 2023 in Review

Copeland Capital Management sold out of Medifast (MED) in Q3 2023, closing a stake of 234 shares — an estimated $21.6K sold.

Copeland Capital Management first reported a position in MED in Q3 2022 and held it in 4 quarters. The position peaked at $31K in Q4 2022. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

  • Copeland Capital Management reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
  • Copeland Capital Management sold 234 Medifast shares in Q3 2023, an estimated $21.6K.
  • Copeland Capital Management first reported a position in Medifast in Q3 2022 and held it in 4 quarters.
  • Copeland Capital Management's Medifast position peaked at $31K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Copeland Capital Management's 13F filing for Q3 2023, filed 23 Oct 2023.